Role of Leptin and SOCS3 in Inhibiting the Type I Interferon Response During Obesity.
Elí Terán-CabanillasJesús Hernández-LopezPublished in: Inflammation (2017)
Obesity provokes an imbalance in the immune system, including an aberrant type I interferon response during some viral infections and after TLR stimulation. SOCS3 overexpression and altered systemic leptin levels could be responsible for the reduced type I interferon production in people with obesity and, eventually, significantly increase the risk of viral infection. The aim of this study was to determine whether SOCS3- and leptin-induced tolerance are responsible for the reduced type I interferon production in people with obesity. SOCS3 overexpression in PBMCs from people with obesity was inhibited with the small interfering RNA (siRNA) assay, and leptin-induced tolerance was evaluated in PBMCs from non-obese volunte\ers and U937 cells treated with TLR ligands. SOCS3, but not SOCS1, gene silencing via siRNA increased the type I interferon response in PBMCs obtained from people with obesity. On the other hand, leptin induced SOCS3 expression and inhibited type I interferons in PBMCs from healthy donors and in U937 monocytes stimulated with TLR ligands. Taken together, these results demonstrate that reduced type I interferon production in obesity is caused by SOCS3 overexpression as well as tolerance induced by leptin. Here, we demonstrate a key role of leptin and SOCS3 in inhibiting the type I interferon response during obesity.
Keyphrases
- weight loss
- metabolic syndrome
- insulin resistance
- type diabetes
- high fat diet induced
- dendritic cells
- weight gain
- inflammatory response
- cell proliferation
- adipose tissue
- immune response
- toll like receptor
- high glucose
- transcription factor
- signaling pathway
- drug delivery
- cancer therapy
- drug induced
- cell death
- long non coding rna